Substituted morpholine and thiomorpholine derivatives
申请人:Tornoe Wenzel Christian
公开号:US20060167248A1
公开(公告)日:2006-07-27
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
本发明涉及通式I的吗啡啶和硫代吗啡啶衍生物或其药学上可接受的盐及其用途。
Methods of using substituted morpholine derivatives
申请人:Tornøe Christian Wenzel
公开号:US20100063033A1
公开(公告)日:2010-03-11
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
本发明涉及一般式I的吗啡啶和硫代吗啡啶衍生物或其药学上可接受的盐以及它们的用途。
SUBSTITUTED THIOMORPHOLINE DERIVATIVES
申请人:Wenzel Tornøe Christian
公开号:US20110294787A1
公开(公告)日:2011-12-01
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
本发明涉及一般式I的吗啡啶和硫代吗啡啶衍生物或其药学上可接受的盐及其用途。
Substituted thiomorpholine derivatives
申请人:H. Lundbeck A/S
公开号:US08299075B2
公开(公告)日:2012-10-30
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.
本发明涉及一般式I的吗啡啶和硫代吗啡啶衍生物或其药学上可接受的盐以及其用途。
METHODS OF USING SUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVES
申请人:Tornoe Christian Wenzel
公开号:US20090143369A1
公开(公告)日:2009-06-04
The present invention relates to morpholine and thiomorpholine derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use.